ZYTOPROTEC

zytoprotec-logo

Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major disease areas. The Company was founded by a team of professionals that combine extensive experience in business administration, clinical research, pharmaceutical product development, as well as company and patent law.

#SimilarOrganizations #People #Financial #Website #More

ZYTOPROTEC

Social Links:

Industry:
Biopharma Biotechnology Medical

Founded:
2007-01-01

Address:
Vienna, Wien, Austria

Country:
Austria

Website Url:
http://www.zytoprotec.com

Total Employee:
11+

Status:
Active

Contact:
43 1 406 20 02

Email Addresses:
[email protected]

Total Funding:
2 M EUR

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon SSL By Default HSTS Nginx Microsoft Exchange Online Office 365 Mail


Similar Organizations

not_available_image

4D pharma Research Ltd

4D pharma Research Limited, a biotechnology company, develops drug compounds from gut bacteria for the prevention.

dorsavi-logo

DorsaVI

DorsaVi is a biotechnology company developing innovative motion analysis device technologies.

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

intercytex-group-logo

Intercytex Group

Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair.

luciole-medical-logo

Luciole Medical

Luciole Medical is a Swiss medical technology company developing brain oxygenation monitoring systems.

mucosis-logo

Mucosis

Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.

neurogeneration-logo

NeuroGeneration

Neurogeneration is a biotechnology company that develops new treatments and products for patients.

pilot-biotechnology-logo

Pilot Biotechnology

Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Employees Featured

christoph-aufricht_image

Christoph Aufricht
Christoph Aufricht Founder & CSO @ Zytoprotec
Founder & CSO

Founder


christoph-aufricht_image

Christoph Aufricht

Investors List

baxter-international_image

Baxter International

Baxter International investment in Series A - Zytoprotec

Official Site Inspections

http://www.zytoprotec.com

  • Host name: pl009.a1webhosting.at
  • IP address: 193.81.82.82
  • Location: Austria
  • Latitude: 48.2
  • Longitude: 16.3667
  • Timezone: Europe/Vienna

Loading ...

More informations about "Zytoprotec"

Zytoprotec - Crunchbase Company Profile & Funding

Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major โ€ฆSee details»

Zytoprotec GMBH / zytoprotec.com

Zytoprotec expects the number of dialysis patients to increase significantly for many years to come. It is estimated that 90% of dialysis fluids contain sugar. The global market for dialysis โ€ฆSee details»

Zytoprotec 2025 Company Profile: Valuation, Funding & Investors

Zytoprotec was founded in 2007. Where is Zytoprotec headquartered? Zytoprotec is headquartered in Vienna, Austria. What is the size of Zytoprotec? Zytoprotec has 10 total โ€ฆSee details»

Zytoprotec Company Profile - Office Locations, Competitors ... - Craft

Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. It offers PD-protec, a patent-protected solution for peritoneal dialysis (PD). In โ€ฆSee details»

Zytoprotec - Overview, News & Similar companies | ZoomInfo.com

Zytoprotec is a clinical stage life sciences company based in Vienna, Austria. The Company's lead product, PD-protec®, is a patent-protected soluti on for peritoneal dialysis. PD-protec® โ€ฆSee details»

ZYTOPROTEC AT A GLANCE

Zytoprotec started this journey in the field of peritoneal dialysis (PD), one of two forms of dialysis, the other being hemodialysis (HD). Dialysis is a necessary, live-saving procedure for patients โ€ฆSee details»

Zytoprotec GmbH - Life Sciences Directory

Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna ... Zytoprotec, a biomedical company founded in 2007, has consistently moved its lead product โ€“ PDprotec® โ€“ โ€ฆSee details»

Zytoprotec - Funding, Financials, Valuation & Investors - Crunchbase

Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How โ€ฆSee details»

Zytoprotec - Crunchbase

Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas. New. Resources. Advanced Search ... Log In. Experience the new โ€ฆSee details»

Zytoprotec GmbH - life-sciences-europe.com

Jan 1, 2007 Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that โ€ฆSee details»

Zytoprotec - VentureRadar

Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that in โ€ฆSee details»

Zytoprotec GmbH:Company Profile & Technical โ€ฆ

Zytoprotec is a company that provides Health care, Orphan drug, Gastrointestinal agent and more. Zytoprotec is headquartered in Austria Wien. Zytoprotec was founded in 2007. and was โ€ฆSee details»

Key Milestones - zytoprotec.com

Zytoprotec opens first Christian-Doppler-Laboratory (a public-private-partnership) aimed at biomarker research in the field of peritoneal dialysis: 06/2014. Start of double-blinded, placebo โ€ฆSee details»

Zytoprotec - 2025 Company Profile, Funding & Competitors - Tracxn

Feb 25, 2025 Zytoprotec - Develops cytoprotective therapies for the treatment of end-stage renal disease (ESRD) and other diseases. Raised a total funding of $2.9M over 2 rounds from 2 โ€ฆSee details»

Life Sciences Directory: Zytoprotec GmbH

Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna ... Zytoprotec, a biomedical company founded in 2007, has consistently moved its lead product โ€“ PDprotec® โ€“ โ€ฆSee details»

Zytoprotec | VentureRadar

Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that in โ€ฆSee details»

Zytoprotec - Products, Competitors, Financials, Employees, โ€ฆ

Zytoprotec specializes in advancing peritoneal dialysis within the healthcare sector, focusing on renal replacement therapies. The company's main product, PDprotec, is a novel dialysate โ€ฆSee details»

NEWS & ARCHIVE - zytoprotec.com

The Zytoprotec team is delighted that this was possible despite the difficult financing environment for start-ups during the last two years. And we would like to thank all new investors for the trust โ€ฆSee details»

What is Zytoprotec? Company Culture, Mission, Values

See what employees say it's like to work at Zytoprotec. Salaries, reviews, and more - all posted by employees working at Zytoprotec.See details»

Science & Technology / zytoprotec.com

Zytoprotecโ€™s science and unique therapeutic approach. During evolution, cells of all species have developed and optimized a powerful mechanism to protect against stress. ... S.G. Zarogiannis, โ€ฆSee details»

linkstock.net © 2022. All rights reserved